Cargando…
Madurella mycetomatis causing eumycetoma medical treatment: The challenges and prospects
Autores principales: | Elkheir, Lamis Y. M., Haroun, Rayan, Mohamed, Magdi Awadalla, Fahal, Ahmed Hassan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7452721/ https://www.ncbi.nlm.nih.gov/pubmed/32853199 http://dx.doi.org/10.1371/journal.pntd.0008307 |
Ejemplares similares
-
Madurella mycetomatis grains within a eumycetoma lesion are clonal
por: Nyuykonge, Bertrand, et al.
Publicado: (2022) -
Madurella mycetomatis, the main causative agent of eumycetoma, is highly susceptible to olorofim
por: Lim, Wilson, et al.
Publicado: (2020) -
Eumycetoma by Madurella mycetomatis with 30 years of
evolution: therapeutic challenge
por: Sampaio, Felipe Maurício Soeiro, et al.
Publicado: (2013) -
Th-1, Th-2 Cytokines Profile among Madurella mycetomatis Eumycetoma Patients
por: Nasr, Amre, et al.
Publicado: (2016) -
The Combination of Amoxicillin-Clavulanic Acid and Ketoconazole in the Treatment of Madurella mycetomatis Eumycetoma and Staphylococcus aureus Co-infection
por: Mhmoud, Najwa A., et al.
Publicado: (2014)